Published in BVentura.


BVentura participa en un proyecto colaborativo de investigación, desarrollo e innovación dentro del marco RIS3CAT

ACCIÓ (The agency for enterprise competitiveness) certified as a RIS3CAT community the technologies applied for health. Within this community, ACCIÓ has selected the project of research, development and innovation tomosynthesis 3D biopsy, in which BVentura participates along with other institutions, such as IDNEO Technologies (FICOSA), the High Energy Physics Institute (IFAE), UDIAT Diagnostic Center – Parc Taulí Sabadell Foundation and the National Microelectronics Centre (CNM) – Centro Superior de Investigaciones Científicas (CSIC).

This project, with file number Comrdi15-1-0022, is co-financed by the European Regional Development Fund (ERDF) from the European Union, within the framework of the operational program ERDF in Catalonia 2014-2020, and is aimed at promoting technical development, innovation and a quality investigation.

The RIS3CAT is a strategy for research and innovation promoted by the European Commission and approved by the Government of Catalonia which identifies seven sectorial leader areas where Catalonia has a competitive advantage, such as health industries and life sciences. It is a commitment to R+D and innovation to encourage economic growth, generate new economic activity and new job opportunities. RIS3CAT communities are groups of companies that drive plans performance R+D and innovation in the identified sectoral areas.

The r+d+i project

The aim of the 3D tomosynthesis biopsy project is to develop innovative products and technologies in the field of biopsy devices. This initiative aims to achieve a more optimal treatment planning and a higher rate of post-treatment patient recovery.

BVentura participates in this project in order to obtain a prototype of scientific instruments that allows testing and validating a new technology with a direct impact on the health system sustainability, which can be applied in other sectors. Also, the initiative works to provide software that may warmly welcome automated processing of medical images.

The Agency for the Competitiveness of the Company (ACCIÓ) accredited the technologies applied to health as a RIS3CAT Community in 2016. 13 RIS3CAT Communities were promoted with a total budget of 53 million euros, some grants managed by ACCIÓ and part of all of which come from the European Regional Development Fund (ERDF). All of them mobilize an investment in research and innovation of over 140 million euros. One of them is part of the sectoral scope of the health and life sciences industries.

Acció - Generalitat de CatalunyaUnió EuropeaUnió Europea - Fons Europeu de Desenvolupament Regional


3D BonT - Biòpsia 3D por tomosíntesi

Go to top